NEO
NeoGenomics Inc
NASDAQ: NEO · HEALTHCARE · DIAGNOSTICS & RESEARCH
$8.96
-0.67% today
Updated 2026-04-29
Market cap
$1.17B
P/E ratio
—
P/S ratio
1.60x
EPS (TTM)
$-0.84
Dividend yield
—
52W range
$5 – $14
Volume
2.1M
WallStSmart proprietary scores
51
out of 100
Grade: C
Hold
Investment rating
8.0
Growth
A5.3
Quality
C+2.0
Profitability
F6.3
Valuation
B3/9
Piotroski F-Score
Weak
1.0
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$13.81
+54.13%
12-Month target
—
—
Intrinsic (DCF)
$54.68
Margin of safety
+79.06%
2 Strong Buy4 Buy7 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 10.60% QoQ
+ 79.06% below intrinsic value
Risks
- Piotroski 3/9 — weak financial health
- Altman Z 0.98 — distress zone
- Thin margins at -14.80%
- Negative free cash flow $-13.14M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $509.73M | $591.64M | $660.57M | $727.33M | $727.33M |
| Net income | $-144.25M | $-87.97M | $-78.73M | $-108.03M | $-17.11M |
| EPS | — | — | — | — | $-0.84 |
| Free cash flow | $-96.88M | $-30.70M | $-34.04M | $-21.78M | $-13.14M |
| Profit margin | -28.30% | -14.87% | -11.92% | -14.85% | -14.80% |
Peer comparison
Smart narrative
NeoGenomics Inc trades at $8.96. Our Smart Value Score of 51/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 0.98, it sits in the distress. TTM revenue stands at $727.33M. with profit margins at -14.80%. Our DCF model estimates intrinsic value at $54.68.
Frequently asked questions
What is NeoGenomics Inc's stock price?
NeoGenomics Inc (NEO) trades at $8.96.
Is NeoGenomics Inc overvalued?
Smart Value Score 51/100 (Grade C, Hold). DCF value $54.68.
What is the price target of NeoGenomics Inc (NEO)?
The analyst target price is $13.81, representing +54.1% upside from the current price of $8.96.
What is the intrinsic value of NeoGenomics Inc (NEO)?
Based on our DCF model, intrinsic value is $54.68, a +79.1% margin of safety versus $8.96.
What is NeoGenomics Inc's revenue?
TTM revenue is $727.33M.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
0.98 — distress.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.60x
ROE-12.40%
Beta1.71
50D MA$8.57
200D MA$9.38
Shares out0.13B
Float0.12B
Short ratio—
Avg volume2.1M
Performance
1 week-0.13%
1 month-18.76%
3 months-34.10%
YTD-34.10%
1 year—
3 years—
5 years—